Blood markers may forecast diabetes cure after gastric bypass

NCT ID NCT05472883

Terminated Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to find blood and tissue markers that could predict whether obese patients with type 2 diabetes would go into remission after bariatric surgery. Researchers planned to measure 9 specific molecules in blood samples and also collect fat and muscle tissue during surgery. The goal was to see if these markers could forecast who would achieve normal blood sugar levels without diabetes medication. However, the study was terminated early and only enrolled 23 participants, so the findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which patients are most likely to see their diabetes go away after bariatric surgery.
What could go wrong: The study was terminated early with only 23 participants, so results may be limited and not apply to everyone. It is an observational biomarker study, not a treatment trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

Toulouse University Hospital

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.